| Literature DB >> 29582130 |
Pauline Marteau1, Catherine Adamsbaum2,3, Linda Rossi-Semerano4, Michel De Bandt5, Irène Lemelle6, Chantal Deslandre7,8, Tu Anh Tran9,10, Anne Lohse11, Elisabeth Solau-Gervais12, Christelle Sordet13, Pascal Pillet14, Brigitte Bader-Meunier15, Julien Wipff16, Cécile Gaujoux-Viala17, Sylvain Breton18, Valérie Devauchelle-Pensec19,20.
Abstract
BACKGROUND: Juvenile idiopathic arthritis (JIA) can cause structural damage. However, data on conventional radiography (CR) in JIA are scant.Entities:
Keywords: Conventional radiography; Erosions; Juvenile idiopathic arthritis; Recommendations; Structural damage
Mesh:
Year: 2018 PMID: 29582130 PMCID: PMC6096609 DOI: 10.1007/s00330-018-5304-7
Source DB: PubMed Journal: Eur Radiol ISSN: 0938-7994 Impact factor: 5.315
Fig. 1.Systematic literature review flow-chart
Details of the studies identified by the systematic literature review
| Article | Design | JIA subtype | Number of patients | Imaging findings used as outcome | Imaging technique | Purpose |
|---|---|---|---|---|---|---|
| Maldonado-Cocco 1980 [ | Prospective | JRA | 100 | Primary | CR | To assess the frequency of carpal ankylosis |
| Williams and Ansell 1985 [ | Retrospective | RF+ pJIA | 81 | Primary | CR | To assess peripheral radiographic progression |
| Poznanski 1991 [ | Narrative review | JRA | NA | NA | CR | To develop a first score for assessing radiographic damage |
| Harel 1993 [ | Prospective | JRA | 23 | Primary | CR | To assess effects of MTX on radiographic progression evaluated based on carpal length |
| Ravelli 1998 [ | Retrospective | pJIA | 26 | Primary | CR | To assess carpal length changes during MTX therapy in pJIA (with bilateral wrist involvement) |
| Guillaume 2000 [ | Prospective | oJIA | 207 | Secondary | CR | To identify prognostic factors in oJIA |
| Al-Matar 2002 [ | Retrospective | oJIA | 205 | Secondary | CR | To identify early features associated with poor outcome in oligoarticular-onset JIA |
| Flatø 2002 [ | Retrospective | JRA, SEA, JPsA, IBD- associated arthritis | 314 | Primary | CR | To assess factors associated with radiographic sacroiliitis in JIA |
| Huemer 2002 [ | Prospective | JPsA, oJIA | 87 | No | NA | To compare clinical features of JPsA and oJIA, including patterns of joint involvement, and to discuss classification |
| Laiho 2002 [ | Cross-sectional | JCA | 159 | Primary | CR | To evaluate radiographic inflammatory changes in the cervical spine |
| Mason 2002 [ | Cross-sectional | Polyarticular JRA | 60 | Primary | CR | To assess the frequency of in hand/wrist CR damage at diagnosis |
| Oen 2002 [ | Narrative review | JIA | NA | NA | NA | To identify outcome predictors, including radiographic findings |
| Bowyer 2003 [ | Retrospective | oJIA, pJIA, sJIA | 703 | Secondary | CR | To assess health status 1 and 5 years after disease onset |
| Doria 2003 [ | Cross-sectional | JRA | 60 | Primary | CR | To assess inter- and intra- observer variability of two scoring systems (Larsen/modified Larsen), comparison to MRI |
| Flatø 2003 [ | Case-control | JRA | 268 | Secondary | CR | To assess long-term prognostic factors |
| Magni-Manzoni 2003 [ | Prospective | pJIA, extended oJIA, sJIA, JPsA, ERA | 94 | Primary | CR | To assess the rate of radiographic progression (Poznanski score) |
| Oen 2003 [ | Retrospective | JRA | 216 | Primary | CR | To assess radiographic damage in early and advanced disease |
| Oen 2003 [ | Retrospective | JRA | 393 | Secondary | CR | To identify early predictors of long-term outcome |
| Ravelli and Martini 2003 [ | Narrative review | All subtypes | NA | NA | NA | To identify early predictors of outcomes, including radiographic outcomes |
| Tsitsami 2003 [ | Retrospective | oJIA, JPsA, UA | 185 | Secondary | CR | To evaluate associations between a familial history of psoriasis and the outcome of oligoarticular JIA |
| Van Rossum 2003 [ | Prospective | pJIA, oJIA, extended oJIA | 67 | Primary | CR | To describe radiographic features |
| Twilt 2004 [ | Cross-sectional | JIA (all subtypes) | 97 | Primary | CR | To evaluate the prevalence of radiographic damage on the OPG |
| Mason 2005 [ | Prospective | Polyarticular JRA | 12 | Primary | CR | To assess radiographic progression after 2 years |
| Van Rossum 2005 [ | Prospective | pJIA, oJIA | 66 | Primary | CR | To assess sensitivity of Dijkstra radiographic score |
| Helenius 2006 [ | Prospective | Adult: RA, AS, SPA, MCTD | 67 | Primary | CR, MRI | To describe clinical, radiographic and MRI findings in rheumatic diseases |
| Rossi 2006 [ | Prospective | pJIA | 25 | Primary | CR | To assess the reliability of the Sharp and Larsen radiographic scoring systems |
| Flatø 2006 [ | Case / control | ERA/oJIA, pJIA | 55/55 | Secondary | CR | To compare clinical, functional and radiological features in ERA versus other JIA subtypes |
| Selvaag 2006 [ | Prospective | sJIA, pJIA, oJIA, ERA | 137 | Primary | CR | To assess radiographic findings at diagnosis and 3-years later |
| Billiau 2007 [ | Prospective | sJIA, RF+ and RF- pJIA, oJIA, ERA, JPsA | 100 | Secondary | CR | To describe clinical, orthodontic, OPG and lateral cephalogram in 46 patients |
| Gilliam 2008 [ | Retrospective | RF+ and RF- pJIA, oJIA, sJIA | 68 | Secondary | CR | To evaluate associations of markers, including radiographic changes, to disease severity |
| Habib 2008 [ | Cross-sectional | pJIA, sJIA, oJIA | 68 | Secondary | CR | To determine the prevalence and significance of ACPAs in JIA |
| Nielsen 2008 [ | Retrospective | extended oJIA, sJIA, pJIA, JPsA | 40 | Primary | CR | To evaluate the radiographic outcome (Poznanski score) during etanercept therapy |
| Pedersen 2008 [ | Prospective | JIA (subtype not specified) | 15 | Primary | CR, MRI | To describe clinical, CRand MRI features; to compare CR to MRI |
| Rostom 2008 [ | Cross-sectional | JIA (all subtypes) | 121 | Primary | CR | To determine the prevalence of clinical and radiological hip involvement |
| Müller 2009 [ | Prospective | JIA (all subtypes) | 30 | Primary | US, MRI | To compare clinical examination/US to MRI |
| Butbul 2009 [ | Retrospective | JPsA, oJIA, pJIA | 106 | No | NA | To compare clinical features in JPsA to other JIA subtypes with similar patterns of joint disease – including growth abnormalities |
| Endén 2009 [ | Cross-sectional | sJIA, pJIA/ fibromyalgia (control) | 134/24 | Primary | CR | To describe growth and cervical vertebrae size in JIA (vs. control) |
| Flatø 2009 [ | Retrospective | JPsA, oJIA, pJIA | 336 | Secondary | CR | To compare JPsA features (including radiographic sacro-iliitis) and outcomes to other JIA subtypes |
| Lin 2009 [ | Cross-sectional | Juvenile AS | 47 juvenile AS, 122 adult AS | Secondary | CR | To compare clinical, laboratory and radiographic features between juvenile and adult-onset AS |
| Tafaghodi 2009 [ | Retrospective | JIA (all subtypes) | 174 | Primary | CR | To assess radiographic characteristics of JIA (118 patients) vs. ALL (56 patients) |
| Arvidsson 2010 [ | Prospective | JRA | 60 | Primary | CR, CT | To assess TMJ imaging during follow-up for long-standing JIA |
| Pagnini 2010 [ | Prospective | ERA | 59 | Primary | CR, MRI | To identify predictors of sacroiliitis |
| Stoll 2010 [ | Retrospective | ERA, JSpA, JPsA | 143 | Primary | CR, MRI | To identify risk factors for sacroiliitis |
| Cannizzaro 2011 [ | Retrospective | oJIA, RF+ and RF- pJIA, JPsA, ERA, sJIA | 223 | Secondary | CR, MRI | To determine the incidence of TMJ involvement in different JIA subtypes |
| Kjellberg 2011 [ | Case-control | pJIA, oJIA, JPsA, ERA, UA | 82 | Primary | CR | To compare radiographic cephalometry findings in JIA and healthy controls |
| Ravelli 2011 [ | Retrospective | oJIA, RF- negative pJIA, JPsA, UA | 971 | Secondary | CR | To compare disease characteristics depending on ANA status |
| Stoll 2011 [ | Retrospective | JPsA | 87/303 | No | NA | To compare clinical features of oJIA vs. JPsA |
| Stoll 2011 [ | Narrative review | JPsA | NA | No | NA | To identify features of JPsA, in comparison with other subtypes of JIA |
| Bertilsson 2012 [ | Prospective | JCA | 132 | Secondary | CR | To prospectively investigate the characteristics and outcome predictors over 5 years of follow-up |
| Lipinska 2012 [ | Prospective | oJIA, pJIA, sJIA | 74 | Secondary | CR | To assess the Steinbrocker score depending on ACPA status |
| Bertilsson 2013 [ | Prospective | JCA | 132 | Secondary | CR | To evaluate long-term outcomes, after 17 years of follow-up |
| Chen 2012 [ | Cross-sectional | Juvenile- onset AS | 67 | Secondary | CR | To compare clinical, laboratory and radiographic features of juvenile-/adult-/late-onset AS |
| Ozawa 2012 [ | Cross-sectional | pJIA, sJIA | 40 | Secondary | CR | To compare radiological and laboratory findings in pJIA and sJIA |
| Abramowicz 2013 [ | Retrospective | JIA | 51 | Primary | MRI | To identify prevalence of synovitis on MRI, TMJ imagingand clinical predictive factors |
| Elhai 2013 [ | Prospective | pJIA | 43 | Primary | CR | To compare radiological outcomes of pJIA at transition vs. matched RA patients |
| Elhai 2013 [ | Cross-sectional | pJIA/RA | 57/58 | Primary | CR | To compare the frequency of cervical spine radiographic damage between long-standing pJIA and RA |
| Jadon 2013 [ | Systematic review | Juvenile-onset AS | NA | NA | CR | To compare clinical, social and radiographic features of adult- vs. juvenile-onset AS |
| Omar 2013 [ | Cross-sectional | oJIA, pJIA, sJIA | 54 | Secondary | CR | To assess correlations linking ACPA presence to the JADAS and Sharp van der Heijde scores |
| Cedströmer 2013[ | Retrospective | oJIA, sJIA, pJIA, JPsA, ERA | 266 | Secondary | CR | To describe clinical findings and disease activity and their associations with CR abnormalities |
| Giancane 2014 [ | Prospective | RF+ and RF- pJIA, sJIA, extended oJIA, UA, JPsA | 186 | Primary | CR | To assess radiographic outcomes during follow-up (1–10 years) |
| Jaremko 2014 [ | Cross-sectional | Juvenile AS | 26 | Primary | CR, MRI | To compare the usefulness of CR and MRI for sacro-iliac joint evaluation at diagnosis of juvenile AS |
| Rodriguez-Lozano 2014 [ | Cross-sectional | sJIA, RF+ and RF- pJIA, JPsA, extended oJIA | 60 CR | NA | CR | To assess the inter-observer reliability of CR interpretation |
| Abramowicz 2014 [ | Retrospective | oJIA, pJIA, JPsA | 30 | Primary | CR, MRI | To identify radiographic findings associated with TMJ synovitis on MRI |
| Górska 2014 [ | Cross-sectional | oJIA, pJIA | 26 | Primary | CR | To describe orthodontic and radiographic findings |
| Koos 2014 [ | Case-control | oJIA, RF- negative pJIA, ERA, JPsA/non-JIA controls | 23/23 | Primary | Cone Beam CT | To describe pathological changes in TMJs |
| Koos 2014[ | Cross-sectional | JIA (all subtypes)/controls | 134/134 | Primary | MRI | To evaluate the reliability of clinical symptoms for diagnosing TMJ synovitis |
| Ringold 2014 [ | Recommendations | pJIA | NA | NA | CR | To develop CARRA recommendations for treating new-onset pJIA |
| Colebatch-Bourn 2015 [ | Recommendations | All subtypes | NA | NA | CR, US, MRI | EULAR recommendations/ all imaging techniques |
| Ravelli 2015 [ | Narrative review | JPsA | NA | NA | No | To assess the classification of JPsA and its relation to oJIA |
| Chan 2016 [ | Prospective | JPsA and non-psoriatic JIA | 57 | No | No | To discuss the classification of JPsA |
| Jadon 2016 [ | Prospective | Adult AS and PsA | 402 | Primary | CR | To compare radiographic features of AS vs. PsA with axial disease |
| Kavanaugh 2016[ | Phase III clinical trial | Adult PsA | 405 | Primary | CR | To assess the efficacy of golimumab on radiographic progression in adult PsA |
| Kristensen 2016 [ | Systematic review | All subtypes | NA | NA | MRI | To identify clinical predictors of TMJ involvement, needing imaging assessment |
| Weiss 2016 [ | Prospective | JSpA | 40 | Primary | CR, MRI | To evaluate the prevalence of sacroiliitis, compared to physical examination findings |
| Guide du bon usage des examens d’imagerie (French online recommendation) [ | Recommendations | NA | NA | NA | CR | To develop recommendations about CR for focal limb pain |
| Ravelli 2014 [ | Clinical trial | pJIA | 87 | Primary | CR | To assess the effect of tocilizumab on pJIA after 2 years, using the van der Heijde and Poznanski scores |
ACPA anti-citrullinated protein antibody, ALL acute lymphoblastic leukaemia, ANA antinuclear antibody, AS ankylosing spondylitis, CARRA Childhood Arthritis and Rheumatology Research Alliance, CR conventional radiography, IBD inflammatory bowel disease, JADAS Juvenile Arthritis Disease Activity Score, JCA juvenile chronic arthritis (former EULAR criteria), JRA juvenile rheumatoid arthritis (former ACR criteria), JPsA juvenile psoriatic arthritis, JSpA juvenile spondyloarthritis, MCTD mixed connective tissue disease, MTX methotrexate, NA not applicable, oJIA oligoarticular juvenile idiopathic arthritis, OPG orthopantomogram, pJIA polyarticular juvenile idiopathic arthritis, SEA seronegative enthesopathy and arthropathy, sJIA systemic juvenile idiopathic arthritis, UA undifferentiated arthritis
Recommendations about CR as a diagnostic and follow-up investigation in non-systemic JIA, with scores for agreement among experts, levels of evidence and grade
| Recommendations | Mean agreement score (±SD) | Level of evidence | Grade |
|---|---|---|---|
|
| |||
| A. A CR assessment is necessary in JIA. | 9.30 (±1.26) | - | - |
| B. The potential risks associated with exposure to ionising radiation must always be considered when using CR. | 9.70 (±0.70) | - | - |
| C. CR is difficult to interpret in skeletally immature patients, particularly those <5 years of age. | 8.95 (±1.73) | - | - |
| D. Other imaging techniques, such as US and MRI, are being developed in JIA, and will be discussed in specific recommendations. | 8.95 (±1.85) | - | - |
|
| |||
| 1. CR should not be performed routinely as a diagnostic investigation. | 8.20 (±1.94) | 3 | C |
| 2 During follow-up, CR should be performed on affected joint(s) that remain symptomatic* after 3 months | 9.10 (±2.17) | 4 | D |
| 3. In patients with persistently symptomatic* joints, the reiteration of CR during follow-up is at the discretion of the physician. | 9.1 5(±1.04) | 4 | D |
| 4. In patients with inactive disease, CR is not recommended. | 9.45 (±0.83) | 4 | D |
| 5. In patients with extended oJIA, the recommendations for pJIA should be applied. | 9.30 (±0.92) | 3 | C |
| 6. In patients with structural damage, the selection and timing of specific imaging techniques to further assess the damaged joint during follow-up is guided by clinical considerations. | 9.15 (±1.04) | 4 | D |
|
| |||
| 7. Routine CR of the wrists, hands, and forefeet is strongly recommended at the diagnosis of polyarticular JIA with positive RF/ACPA. | 9.30 (±1.26) | 2B, 3 | B |
| 8. CR of other joints than wrists, hands, and forefeet, is recommended at the diagnosis for symptomatic* joints only. | 9.00 (±1.49) | 2B,3 | B |
| 9. In new-onset RF/ACPA-negative pJIA with adverse prognostic factors, CR at diagnosis should be performed as for RF/ACPA-positive pJIA (recommendation #7). | 8.55 (±2.46) | 3 | C |
| 10. Adverse prognostic factors are early wrist involvement, distal involvement, symmetric arthritis, high CRP/ESR, and bone erosions. | 9.35 (±0.81) | 2B | B |
| 11. In new-onset, RF/ACPA-negative pJIA without adverse prognostic factors, at diagnosis, CR should be confined to symptomatic* joints. | 8.15 (±2.28) | 4 | D |
| 12. In RF/ACPA-positive pJIA, CR of the hands, wrists, and forefeet is strongly recommended | 8.6 (±1.31) | 2A, 2B | B |
| - 1 year after disease onset | 8.30 (±1.72) | 2B | B |
| - and when transitioning from paediatric to adult healthcare | 8.85 (±0.99) | 4 | D |
| At other time points, the use of CR during follow-up is at the discretion of the physician. | 9.25 (±0.85) | 4 | D |
| 13. Routine CR of other joints is not recommended. | 9.40 (±0.75) | 4 | D |
| 14. During the follow-up of RF/ACPA-negative pJIA with adverse prognostic factors, CR should be performed as for RF/ACPA-positive pJIA (recommendation #12). | 9.00 (±2.03) | 3 | C |
| 15. During the follow-up of RF/ACPA-negative pJIA without adverse prognostic factors, the use of CR is at the discretion of the physician. | 9.50 (±1.17) | 4 | D |
| 16. CR can be repeated in patients who remain symptomatic longer than 3 months. | 8.25 (±2.10) | 4 | D |
| 17. In patients with structural damage, the selection and timing of specific imaging techniques during follow-up is guided by clinical considerations. | 9.35 (±0.81) | 4 | D |
|
| |||
| 18. In patients with axial ERA, CR of the spine and hip joints should be performed only when needed for the differential diagnosis. | 8.05 (±2.42) | 4 | D |
| 19. During the follow-up of axial ERA, CR should be considered only for the hip joints, depending on the clinical course and availability of US and/or MRI. | 8.90 (±1.33) | 3 | C |
| 20. CR is not recommended for multifocal enthesitis. | 9.10 (±0.97) | 4 | D |
| 21. In patients with isolated enthesitis, CR can be considered as a tool for establishing the differential diagnosis. | 8.35 (±2.43) | 4 | D |
|
| |||
| 22. No specific recommendation can be made about CR in juvenile psoriatic arthritis. | 9.20 (±0.83) | 4 | D |
| 23. Guidance may be taken from the recommendations above, depending on the clinical presentation, or from recommendations issued for adults. | 9.35 (±0.74) | 4 | D |
|
| |||
| | |||
| 24. At the diagnosis of acute monoarthritis, CR of the involved joint should be performed, with two perpendicular views. | 9.35 (±1.04) | 3 | C |
| 25. At the diagnosis of acute monoarthritis, comparative CR of the contralateral joint is unnecessary. | 8.50 (±2.39) | 4 | D |
| 26. In patients with persistent neck pain related to JIA, MRI is preferable over CR. | 9.60 (±0.68) | 4 | D |
| 27. When MRI is unavailable, CR is recommended only for the cervical spine and should consist only in a lateral view. | 8.80 (±1.56) | 4 | D |
| 28. In patients with JIA who have neurological symptoms of spinal cord compression and neck pain, cervical MRI must be performed, on an emergency basis. | 9.80 (±0.52) | 3 | C |
| 29. CR of the TMJs is not recommended when cross-sectional imaging is available. | 9.20 (±1.47) | 3 | C |
| 30. Routine CR of the hip joint is not recommended in patients with pJIA. | 9.25 (±1.02) | 3 | C |
| 31. When CR of a symptomatic hip joint is performed, a single view should be obtained, i.e., either an antero-posterior view or a frog leg view. | 9.05 (±1.28) | 4 | D |
JIA juvenile idiopathic arthritis, CR conventional radiography, oJIA oligoarticular juvenile idiopathic arthritis, pJIA polyarticular juvenile idiopathic arthritis, RF rheumatoid factor, ACPA anti-citrullinated protein antibody, ERA enthesitis-related arthritis, TMJ temporo-mandibular joint
*Symptomatic joints: swollen and/or painful joints, and/or joints with motion range limitation
| Early involvement of wrists |
| - Follow-up of a cohort of patients with recent-onset RF/ACPA-positive polyarticular JIA, with annual CR for 10 years to identify predictors of structural joint damage |